Brokerages Set Clorox Company (The) (CLX) Price Target at $125.42

Clorox Company (The) (NYSE:CLX) has been assigned a consensus rating of “Hold” from the fourteen research firms that are presently covering the stock, MarketBeat reports. Three investment analysts have rated the stock with a sell recommendation, nine have issued a hold recommendation and two have issued a buy recommendation on the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $125.42.

A number of research analysts have commented on CLX shares. Zacks Investment Research lowered Clorox Company (The) from a “hold” rating to a “sell” rating in a research report on Wednesday, October 4th. BidaskClub lowered Clorox Company (The) from a “hold” rating to a “sell” rating in a research report on Wednesday, July 5th. Jefferies Group LLC restated a “hold” rating and issued a $132.00 price target (down from $137.00) on shares of Clorox Company (The) in a research report on Friday, October 6th. Deutsche Bank AG restated a “hold” rating and issued a $137.00 price target (up from $126.00) on shares of Clorox Company (The) in a research report on Saturday, July 22nd. Finally, BMO Capital Markets restated a “buy” rating and issued a $150.00 price target on shares of Clorox Company (The) in a research report on Thursday, October 5th.

ILLEGAL ACTIVITY NOTICE: “Brokerages Set Clorox Company (The) (CLX) Price Target at $125.42” was reported by TrueBlueTribune and is the property of of TrueBlueTribune. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US & international copyright legislation. The legal version of this piece of content can be accessed at https://www.truebluetribune.com/2017/11/14/brokerages-set-clorox-company-the-clx-price-target-at-125-42.html.

In related news, SVP Jon M. Balousek sold 9,223 shares of Clorox Company (The) stock in a transaction dated Wednesday, August 23rd. The stock was sold at an average price of $138.87, for a total value of $1,280,798.01. Following the sale, the senior vice president now owns 20,614 shares of the company’s stock, valued at $2,862,666.18. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Dawn C. Willoughby sold 2,158 shares of Clorox Company (The) stock in a transaction dated Tuesday, August 29th. The shares were sold at an average price of $138.00, for a total value of $297,804.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 21,242 shares of company stock worth $2,944,449. 1.00% of the stock is owned by company insiders.

A number of hedge funds and other institutional investors have recently made changes to their positions in CLX. American Beacon Advisors Inc. acquired a new position in Clorox Company (The) during the first quarter worth approximately $104,000. Parkside Financial Bank & Trust increased its position in Clorox Company (The) by 3.8% during the second quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock worth $107,000 after buying an additional 29 shares during the last quarter. Valley National Advisers Inc. increased its position in Clorox Company (The) by 0.6% during the second quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock worth $115,000 after buying an additional 5 shares during the last quarter. Blue Chip Partners Inc. increased its position in Clorox Company (The) by 3.9% during the second quarter. Blue Chip Partners Inc. now owns 941 shares of the company’s stock worth $125,000 after buying an additional 35 shares during the last quarter. Finally, Sun Life Financial INC increased its position in Clorox Company (The) by 10,344.4% during the second quarter. Sun Life Financial INC now owns 940 shares of the company’s stock worth $125,000 after buying an additional 931 shares during the last quarter. 71.30% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Clorox Company (NYSE CLX) traded down 0.65% on Thursday, reaching $127.03. The company’s stock had a trading volume of 1,128,875 shares. The stock has a market capitalization of $16.40 billion, a price-to-earnings ratio of 23.81 and a beta of 0.39. Clorox Company has a 52 week low of $111.24 and a 52 week high of $141.76. The stock has a 50-day moving average of $131.17 and a 200 day moving average of $133.94.

Clorox Company (The) (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, beating the Zacks’ consensus estimate of $1.49 by $0.04. The firm had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.65 billion. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The business’s quarterly revenue was up 2.9% compared to the same quarter last year. During the same period last year, the company earned $1.30 EPS. On average, analysts expect that Clorox Company will post $5.64 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Monday, November 13th. Shareholders of record on Wednesday, October 25th will be paid a $0.84 dividend. This represents a $3.36 annualized dividend and a dividend yield of 2.65%. The ex-dividend date of this dividend is Tuesday, October 24th. Clorox Company (The)’s dividend payout ratio is 63.04%.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply